您要查找的是不是：
- Suggest metabolites for the proton pump inhibitor Omeprazole. 指出質(zhì)子泵抑制劑奧美拉唑的代謝物。
- Esomeprazole,a new proton pump inhibitor,is the S-i somer of omeprazole. 艾司奧美拉唑是一種新型的質(zhì)子泵抑制劑，它是奧美拉唑的S-型光學(xué)異構體。
- Nexium is part of a class of drugs known as proton pump inhibitors (PPIs). 耐信是質(zhì)子泵抑制劑（PPI）奧美拉唑的一種異構體。
- Bacteriorhodopsin acts as a light-activated proton pump that provides energy for cell functions. 細菌視紫紅質(zhì)作為光激活質(zhì)子泵，以提供細胞功能的能量。
- Esomeprazole is a new member of proton pump inhibitors(PPI) with strong suppressive effects on gastric acid secretion. 埃索美拉唑是新一代質(zhì)子泵抑制劑成員,有較強的抑制胃酸分泌效應。
- Proton pump inhibitors were metabolized with the sub-enzyme CYP2C19 of microsomes P450. 質(zhì)子泵抑制劑奧美拉唑、蘭索拉唑和盤(pán)托拉唑主要經(jīng)細胞色素P450(CYP)的異構酶CYP2C19代謝消除。
- Proton pump inhibitor (PPI) Losec seems to be the best medication for the elderly upper gastrointestinal bleeding. 質(zhì)子泵抑制劑洛賽克治療老年上消化道出血療效顯著(zhù)。
- Three proton pump inhibitors have been launched: omeprazole, lansoprazole and pantoprazole in 1988,1991 and 1994, respectively. 已經(jīng)上市的質(zhì)子泵抑制劑有奧美拉唑(1988年上市)、蘭索拉唑(1991年上市)、泮妥拉唑(1994年上市)。
- For patients with ulcer bleeding and low-risk endoscopic stigmata, high-dose oral proton pump inhibitor therapy is suggested. 對潰瘍出血和低危內窺鏡顯小孔的患者，建議應口服大劑量質(zhì)子泵抑制劑。
- Results: Proton pump inhibitors took up the highest proportion of use frequency and money spent on antiulcer drugs in hospitalised patients. 結果：質(zhì)子泵抑制劑的用藥頻數和用藥金額在住院患者抗消化性潰瘍藥物應用中居首位。
- Objective To evaluate the therapeutic effectiveness of the proton pump inhibitor (losec) to prevent gastroenteric reaction induced by chemotherapy. 摘要目的觀(guān)察質(zhì)子泵抑制劑（洛賽克）在化療過(guò)程中對胃腸道反應的預防保護作用。
- This result imply heterotrimeric G proteins may be a upstream regulator of proton pump or of no direct relation to proton pump. 推測異三聚體G蛋白在花粉細胞信號轉導過(guò)程中可能存在于質(zhì)子泵的上游,也可能與質(zhì)子泵沒(méi)有直接關(guān)系。
- Active proton pump on the pollen grain membrane drives H+ efflux, hyperpolarize the membrane and triggers signaling transduction. 花粉細胞質(zhì)膜上存在質(zhì)子泵,由其活化導致的H+外流可以影響細胞膜電位,引發(fā)一系列信號轉導過(guò)程。
- It seems that heterotrimeric G-protein locate on upstream of proton pump,or there is no direct relation between these two signal transducers. 推測異三聚體G蛋白在保衛細胞信號轉導過(guò)程中可能存在于質(zhì)子泵的上游,也可能與質(zhì)子泵沒(méi)有直接關(guān)系。
- This is possible because stomach acid is needed to help the body absorb calcium - proton pump inhibitors work by slowing the production of stomach acid. 這項研究結果是可能的因為機體需要胃酸幫助吸收鈣而質(zhì)子泵抑制劑通過(guò)減少胃酸的產(chǎn)生發(fā)揮作用。
- Medical management with proton pump inhibitors is not a substitute for appropriate endoscopic therapy for patients with UGI bleeding and high-risk ulcer stigmata. 對高位胃潰瘍出血和高危潰瘍顯小孔的患者除質(zhì)子泵抑制劑治療外，不能代替掉適當的內窺鏡治療。
- But the drugs raise the risk of stomach bleeding, so they also prescribe Nexium, made by AstraZeneca, or a rival drug in a group known as proton pump inhibitors. 但這些藥物提高了胃出血的危險，因此醫生也會(huì )開(kāi)阿斯利康制藥公司制作的艾美拉唑，或對手的藥物作為質(zhì)子泵抑制劑。
- The results of several studies and meta-analyses favour high-dose, intravenous proton pump inhibitors, such as omeprazole or pantoprazole, after successful endoscopic haemostasis. 根據幾種研究結果和分析結果證明，靜注大劑量質(zhì)子原抑制劑，例如拌托啦唑、奧米啦唑、在成功的內鏡止血后進(jìn)行治療很有效。
- Conclusion The proton pump inhibitor combined routine antinauseants can prevent gastroenteric reaction induced by chemotherapy and improve the QOL of patients. 結論質(zhì)子泵抑制劑聯(lián)合止吐劑臨床應用，可以預防化療所致的胃腸道反應并能改善化療病人的生活質(zhì)量。
- All effects are dependent on their causes. 一切的結果都基于它們的原因。
